Lipoprotéine(a): de l'athérosclérose à Alzheimer [Lipoprotein (a) in Alzheimer's atherosclerosis].

Détails

ID Serval
serval:BIB_AB9B1C67C206
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Lipoprotéine(a): de l'athérosclérose à Alzheimer [Lipoprotein (a) in Alzheimer's atherosclerosis].
Périodique
Revue Médicale de la Suisse Romande
Auteur⸱e⸱s
Mooser V.
ISSN
0035-3655 (Print)
ISSN-L
0035-3655
Statut éditorial
Publié
Date de publication
2000
Volume
120
Numéro
11
Pages
903-906
Langue
français
Notes
Publication types: English Abstract ; Journal Article ; Review
Résumé
Lipoprotein(a) [Lp(a)] is an enigmatic lipoprotein particle present in the plasma from humans, great apes and hedgehogs. Plasma levels of Lp(a) vary widely between individuals and are largely determined by specific sequences within the gene encoding apo(a), the unique highly polymorphic glycoprotein attached to apoB of low density lipoprotein (LDL) to form Lp(a). Elevated plasma concentrations of LP(a) are associated with the premature development of atherosclerosis. A major goal of our laboratory is to better understand the metabolism of Lp(a) and its function in humans. We have identified unexpected and large variations in plasma Lp(a) levels during renal disease, HIV-infection and in sepsis. Moreover, we have observed an association between Lp(a) and Alzheimer disease. Taken together, our observations suggest that Lp(a) may constitute a novel target in our fight against cardiovascular and neurodegenerative disorders.
Mots-clé
Alzheimer Disease/blood, Alzheimer Disease/etiology, Apolipoproteins E/blood, Arteriosclerosis/blood, Arteriosclerosis/etiology, Humans, Lipoprotein(a)/blood
Pubmed
Création de la notice
13/10/2013 21:55
Dernière modification de la notice
20/08/2019 16:15
Données d'usage